Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation.

Ciancio, G

Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation. [electronic resource] - Transplantation proceedings Nov 2010 - 3503-6 p. digital

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial

1873-2623

10.1016/j.transproceed.2010.08.045 doi


Adult
Alemtuzumab
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm--administration & dosage
Antilymphocyte Serum
Biomarkers--blood
Biopsy
Chi-Square Distribution
Creatinine--blood
Daclizumab
Drug Therapy, Combination
Female
Florida
Graft Rejection--immunology
Humans
Immunoglobulin G--administration & dosage
Immunosuppressive Agents--administration & dosage
Kaplan-Meier Estimate
Kidney Function Tests
Kidney Transplantation--adverse effects
Male
Middle Aged
Mycophenolic Acid--administration & dosage
Prospective Studies
Risk Assessment
Risk Factors
Steroids--administration & dosage
Tacrolimus--administration & dosage
Time Factors
Transplantation, Homologous
Treatment Outcome